Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.36 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.36 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18413007 | 0.91 | TSHR (0.56) | ALDH1A1LMNAHSD17B10TSHRGLA | |
| SCHEMBL19448939 | 0.88 | ALDH1A1 (0.39) | ALDH1A1LMNAHSD17B10TSHRGLA | |
| SCHEMBL19509027 | 0.84 | CYP3A4 (0.63) | ALDH1A1TSHRCYP3A4 | |
| SCHEMBL18239571 | 0.83 | ALDH1A1 (0.34) | ALDH1A1LMNAHSD17B10GLABTN3A1 | |
| SCHEMBL18239570 | 0.83 | CTSA (0.38) | ALDH1A1LMNAHSD17B10TSHRGLA | |
| SCHEMBL13301617 | 0.82 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10TSHRGLA | |
| SCHEMBL10378936 | 0.82 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10TSHRGLA | |
| SCHEMBL5167134 | 0.82 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10TSHRGLA | |
| SCHEMBL14019302 | 0.80 | ALDH1A1 (0.40) | ALDH1A1LMNAHSD17B10TSHRGLA | |
| SCHEMBL18235500 | 0.80 | GLA (0.37) | ALDH1A1LMNAHSD17B10GLAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9670145-B2 | Process for preparing 1,1-disubstituted ethylene monomers | AFINITICA TECHNOLOGIES, S. L. (ES) | 2017-06-06 | — | — | US | disclosed |
| EP-2927209-A1 | Process for preparing 1,1-disubstituted ethylenic monomers | Afinitica Technologies, S. L. (ES) | 2015-10-07 | — | — | EP | disclosed |
| EP-0842181-B1 | MEMBRANE-PERMEANT SECOND MESSENGERS | UNIV CALIFORNIA (US) | 2002-10-02 | — | — | EP | disclosed |
| US-5866548-A | ACTIVATION BY ULTRAVIOLET LIGHT | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1999-02-02 | — | — | US | disclosed |
| EP-0842181-A4 | MEMBRANE-PERMEANT SECOND MESSENGERS | UNIV CALIFORNIA (US) | 1998-11-25 | — | — | EP | disclosed |
| US-5834436-A | CYCLOHEXANES SUBSTITUTED BY ACYLOXYALKYL PHOSPHATE ESTERS AS CARRIERS WHICH CAN PENETRATE CELL MEMBRANES WITHOUT DISRUPTING IT; | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-11-10 | — | — | US | disclosed |
| WO-1998026786-A1 | CAGED MEMBRANE-PERMEANT INOSITOL PHOSPHATES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-06-25 | — | — | WO | disclosed |
| EP-0842181-A1 | MEMBRANE-PERMEANT SECOND MESSENGERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-05-20 | — | — | EP | disclosed |
| US-5693521-A | USING ACETOXYALKYL ESTER OF ADENOSINE(OR GUANOSINE)-3',5'-CYCLIC MONNOPHOSPHATE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-12-02 | — | — | US | disclosed |
| WO-1996040695-A1 | MEMBRANE-PERMEANT SECOND MESSENGERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1994023724-A1 | MEMBRANE-PERMEANT SECOND MESSENGERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1994-10-27 | — | — | WO | disclosed |